BELLUS Health Inc (BLU)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Roberto Bellini
Employees:
40
275 ARMAND-FRAPPIER BLVD., LAVAL, A8, H7V 4A7
450-680-4500
-
Formally known as:
- BELLUS HEALTH INC NEW COM SHS
- BELLUS Health Inc.
- Neurochem Inc.
Are you looking for this stock instead?
Date | Ratio |
---|---|
2012-05-29 | 1:30 |
BELLUS Health Inc. develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|